Chul-Joong Kim Selected Research

poly(gamma-glutamic acid) (gamma-PGA)

3/2017	Mucosal vaccination of conserved sM2, HA2 and cholera toxin subunit A1 (CTA1) fusion protein with poly gamma-glutamate/chitosan nanoparticles (PC NPs) induces protection against divergent influenza subtypes.
10/2015	Intranasal administration of poly-gamma glutamate induced antiviral activity and protective immune responses against H1N1 influenza A virus infection.
12/2012	Mucosal immunization with recombinant influenza hemagglutinin protein and poly gamma-glutamate/chitosan nanoparticles induces protection against highly pathogenic influenza A virus.
5/2010	Immunogenicity and protective efficacy of orally or intranasally administered recombinant Lactobacillus casei expressing ETEC K99.
4/2010	Effects of ultra high molecular weight poly-gamma-glutamic acid from Bacillus subtilis (chungkookjang) on corneal wound healing.
7/2009	Induction of immune responses in mice after oral immunization with recombinant Lactobacillus casei strains expressing enterotoxigenic Escherichia coli F41 fimbrial protein.
1/2005	Natural and edible biopolymer poly-gamma-glutamic acid: synthesis, production, and applications.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chul-Joong Kim Research Topics

Disease

19	Infections 11/2020 - 02/2006
13	Human Influenza (Influenza) 03/2017 - 04/2012
9	Influenza in Birds (Avian Flu) 01/2018 - 05/2009
8	Virus Diseases (Viral Diseases) 11/2020 - 12/2009
4	Neoplasms (Cancer) 10/2006 - 03/2002
2	RNA Virus Infections 01/2018 - 05/2017
2	Vesicular Stomatitis 01/2017 - 01/2015
2	Inflammation (Inflammations) 04/2013 - 08/2003
2	Orthomyxoviridae Infections 12/2008 - 11/2006
1	Bacterial Infections (Bacterial Infection) 01/2019
1	Listeriosis (Listeria Infection) 01/2019
1	Burns 04/2010
1	Severe Acute Respiratory Syndrome 04/2006
1	Glioblastoma (Glioblastoma Multiforme) 03/2006
1	Necrosis 02/2006

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 11/2020 - 02/2006
12	VaccinesIBA 01/2019 - 05/2009
10	Antiviral Agents (Antivirals)IBA 01/2019 - 04/2012
8	CytokinesIBA 01/2019 - 08/2003
7	poly(gamma-glutamic acid) (gamma-PGA)IBA 03/2017 - 01/2005
4	Interferon Type IIBA 01/2018 - 01/2015
4	AntigensIBA 10/2015 - 12/2009
4	AntibodiesIBA 12/2013 - 04/2006
3	Prostaglandins AIBA 10/2015 - 04/2012
3	Influenza Vaccines (Influenza Vaccine)FDA Link 09/2015 - 12/2012
3	Surface Antigens (Surface Antigen)IBA 12/2013 - 07/2009
3	Hemagglutinins (Hemagglutinin)IBA 10/2013 - 11/2006
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019 - 03/2012
2	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2019 - 03/2012
2	Neuraminidase (Sialidase)IBA 01/2018 - 10/2013
2	ChitosanIBA 03/2017 - 12/2012
2	Cholera ToxinIBA 03/2017 - 09/2015
2	Peptides (Polypeptides)IBA 01/2017 - 12/2013
2	Ligases (Synthetase)IBA 05/2010 - 07/2009
2	AngiostatinsIBA 03/2006 - 03/2002
1	InterferonsIBA 11/2020
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 11/2020
1	Tryptophan-tRNA LigaseIBA 01/2019
1	Amino Acids FDA Link 01/2019
1	EnzymesIBA 01/2019
1	CREB-Binding ProteinIBA 01/2019
1	CateninsIBA 01/2019
1	Toll-Like Receptor 4IBA 01/2019
1	aluminum sulfate (alum)IBA 11/2016
1	Death Domain ReceptorsIBA 11/2015
1	Interleukin-12 (IL 12)IBA 10/2015
1	Biocompatible Materials (Biomaterials)IBA 10/2015
1	Interferon-betaIBA 10/2015
1	Attenuated VaccinesIBA 07/2015
1	Plant ExtractsIBA 01/2015
1	Recombinant ProteinsIBA 12/2013
1	ChemokinesIBA 04/2013
1	Myxovirus Resistance ProteinsIBA 04/2013
1	Glutamic Acid (Glutamate)FDA Link 12/2012
1	Toll-Like Receptor 2IBA 03/2012
1	AlkaliesIBA 04/2010
1	Heterogeneous-Nuclear Ribonucleoprotein Group F-HIBA 02/2010
1	Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA 02/2010
1	Isoleucine (L-Isoleucine)FDA Link 12/2009
1	Environmental BiomarkersIBA 05/2009
1	Membrane Proteins (Integral Membrane Proteins)IBA 05/2009
1	Viral RNAIBA 11/2006
1	Human papillomavirus type 16 oncogene protein E7IBA 10/2006
1	Annexin A5IBA 02/2006
1	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 02/2006
1	alpha-MSHIBA 08/2003
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2003
1	NeuropeptidesIBA 08/2003
1	Cell Surface ReceptorsIBA 08/2003

Therapy/Procedure

3	Intranasal Administration 01/2019 - 12/2012
1	Mucosal Administration 09/2015
1	Oral Administration 01/2015
1	Therapeutics 03/2006